Tuesday morning at NHIA 2025 featured a breakfast symposium and our innovative 30-30-30 sessions that cover a central topic from 3 angles with unique perspectives. For example, IV workflow systems were examined from history of their development and use in hospital systems, to their current adoption in home infusion practice, and how to implement such a system if your organization chooses to operationalize one.
Monday morning kicked off with a high-octane networking breakfast before the General Session. We were fortunate to hear from Dr. Mark McClellan, who was FDA Commissioner and CMS Administrator under the George W. Bush administration, who joined NHIA President and CEO Connie Sullivan for a fireside chat.
NHIA 2025 convened the largest gathering dedicated to the home and alternate site infusion industry in Washington, D.C., featuring the event’s most extensive Expo ever with 150 product and service suppliers supporting the industry, including 39 first-time exhibitors. The conference continued to see an increase in individuals investing to attend the conference and nearly 1,600 industry professionals attended the 5-day event.
This retrospective analysis investigates the occurrence of acute kidney injury in pts with type 2 diabetes who receive vancomycin via home infusion. The study aims to shed a light on the prevalence, risk factors and mgmt. strategies related to AKI in this specific pt population.
Let’s discuss how to build a compounding pharmacy training program then join me at our roundtables for some fun hands-on aseptic technique training with my fellow sterile compounding experts!
A home infusion provider transitioning to innovative technologies paving the way to integrating artificial intelligence to increase patient engagement, improve quality outcomes, and reduce cost.
This session will provide a solid foundation for an organization to develop and implement an effective hazard communication program.
Want to get more out of those expensive reports? Let us show you how.
An interactive workshop examining claims, audits and denials for home enteral nutrition (EN) and parenteral nutrition (PN). Attendees will briefly review key revenue cycle management (RCM) concepts specific to home EN and PN. In groups, participants will then work through sample claims, identifying and discussing barriers to EN and PN reimbursement.
Pharmacy Technicians continuously evolve by fulfilling the role of the designated person in key areas of the new USP revision.
Tuesday morning at NHIA 2025 featured a breakfast symposium and our innovative 30-30-30 sessions that cover a central topic from 3 angles with unique perspectives. For example, IV workflow systems were examined from history of their development and use in hospital systems, to their current adoption in home infusion practice, and how to implement such a system if your organization chooses to operationalize one.
Monday morning kicked off with a high-octane networking breakfast before the General Session. We were fortunate to hear from Dr. Mark McClellan, who was FDA Commissioner and CMS Administrator under the George W. Bush administration, who joined NHIA President and CEO Connie Sullivan for a fireside chat.
NHIA 2025 convened the largest gathering dedicated to the home and alternate site infusion industry in Washington, D.C., featuring the event’s most extensive Expo ever with 150 product and service suppliers supporting the industry, including 39 first-time exhibitors. The conference continued to see an increase in individuals investing to attend the conference and nearly 1,600 industry professionals attended the 5-day event.
This retrospective analysis investigates the occurrence of acute kidney injury in pts with type 2 diabetes who receive vancomycin via home infusion. The study aims to shed a light on the prevalence, risk factors and mgmt. strategies related to AKI in this specific pt population.
